The Clinical Development and Operations team at UCB plays a crucial role in advancing the company’s biopharmaceutical innovations, focusing on the design, execution, and oversight of clinical trials in neurodegenerative and immunological diseases. This multidisciplinary team collaborates to ensure compliance with regulatory standards, manage clinical sites, analyze data, and facilitate communication between stakeholders, driving projects from early-stage development through to successful clinical outcomes. Their ultimate goal is to deliver safe and effective therapies to patients in need.